A new study published in February 2026 has identified SLC25A20, a mitochondrial transport protein (also known as carnitine-acylcarnitine translocase), as a key player in how the body processes dietary fat. The research highlights SLC25A20’s critical role in promoting carnitine synthesis, especially in mice consuming high-fat diets.
How SLC25A20 Works
When mice eat a high-fat diet, their cells increase the production of SLC25A20. This protein not only shuttles fatty acids into the mitochondria for energy (beta-oxidation), but it also signals the liver to boost the synthesis of L-carnitine—the “shuttle” molecule that carries long-chain fatty acids into the mitochondrial matrix.
Consequences of Protein Deficiency
The study found that mice lacking SLC25A20 were unable to efficiently burn dietary fats, even when their calorie intake was controlled. As a result, these mice rapidly gained weight and developed fatty liver disease, indicating a severe metabolic bottleneck.
Implications for Obesity and Metabolic Syndrome
Researchers suggest that targeting the SLC25A20 pathway could help treat obesity and metabolic syndrome in humans. By enhancing this protein’s activity, it may become possible to encourage the body to burn fat instead of storing it.
Scientific Context
As highlighted by Nature Communications and ScienceDaily, this research expands our understanding of how mitochondria sense nutrient availability and regulate the body’s chemistry to prevent metabolic “traffic jams.” Further studies on SLC25A20 could pave the way for new therapies in metabolic health and weight management.







